About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Egfr
epidermal growth factor receptor
MGI:95294
196 phenotypes from 15 alleles in 30 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Egfrm2Btlr/Egfrm2Btlr
C57BL/6J-Egfrm2Btlr 		disheveled coat J:231805
rough coat J:231805
thick skin J:231805
EgfrMhdadsk5/Egfr+
C3HeB/FeJ-EgfrMhdadsk5/Ieg 		abnormal nail morphology J:81301
abnormal skin pigmentation J:81301
increased foot pad pigmentation J:81301
thick epidermis J:81301
waved hair J:81301
EgfrMhdadsk5/Egfr+
involves: 129S1/SvImJ * C3HeB/FeJ 		increased susceptibility to Coronaviridae infection J:243599
increased susceptibility to Coronaviridae infection induced morbidity/mortality J:243599
EgfrMhdadsk5/EgfrMhdadsk5
involves: C3HeB/FeJ * C57BL/6J 		abnormal skin pigmentation J:81301
increased foot pad pigmentation J:81301
long toenails J:81301
thick epidermis J:81301
waved hair J:81301
Egfrtm1.1Dwt/Egfrtm1.1Dwt
involves: 129S6/SvEvTac 		abnormal dorsal root ganglion morphology J:145069
abnormal hair follicle morphology J:145069
abnormal sensory neuron innervation pattern J:145069
Egfrtm1.1Tyj/Egfrtm1.1Tyj
involves: 129 * C57BL/6 		embryonic lethality, complete penetrance J:101977
Egfrtm1a(EUCOMM)Wtsi/Egfr+
C57BL/6N-Egfrtm1a(EUCOMM)Wtsi/Wtsi 		decreased leukocyte cell number J:175295
Egfrtm1Dwt/Egfrtm1Dwt
Sox9tm3(cre)Crm/Sox9+
involves: 129S6/SvEvTac * 129S7/SvEvBrd 		abnormal epidermal layer morphology J:229771
abnormal skin morphology J:229771
dermatitis J:229771
impaired skin barrier function J:229771
increased IgE level J:229771
increased T-helper 1 cell number J:229771
increased T-helper 2 cell number J:229771
increased T-helper 17 cell number J:229771
Egfrtm1Dwt/Egfrtm1Dwt
Tg(EIIa-cre)C5379Lmgd/0
involves: 129S6/SvEvTac * C57BL/6J * FVB/N 		abnormal placenta labyrinth morphology J:145161
abnormal spongiotrophoblast layer morphology J:145161
decreased embryo size J:145161
placental labyrinth hypoplasia J:145161
Egfrtm1Dwt/Egfrtm1Dwt
Tg(KRT14-cre)1Amc/0
involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA 		waved hair J:145161
Egfrtm1Dwt/Egfrtm1Dwt
Tg(KRT14-cre)1Amc/0
involves: 129S6/SvEvTac * C57BL/6 * CBA 		abnormal hair follicle morphology J:145069
normal nervous system phenotype J:145069
Egfrtm1Dwt/Egfrtm1Mag
involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J 		normal growth/size/body region phenotype J:145161
normal integument phenotype J:145161
normal reproductive system phenotype J:145161
Egfrtm1Mag/Egfrtm1Mag
involves: 129/Sv * 129S2/SvPas 		abnormal placenta labyrinth morphology J:26833
decreased spongiotrophoblast size J:26833
decreased trophoblast giant cell number J:26833
embryonic lethality at implantation, complete penetrance J:26833
embryonic lethality during organogenesis, complete penetrance J:26833
perinatal lethality, complete penetrance J:26833
small placenta J:26833
Egfrtm1Mag/Egfrtm1Mag
involves: 129S2/SvPas * CD-1 		abnormal cerebellum external granule cell layer morphology J:26833
abnormal cerebral cortex morphology J:26833
abnormal coat appearance J:26833
abnormal colon morphology J:26833
abnormal esophageal epithelium morphology J:26833
abnormal filiform papillae morphology J:26833
abnormal fungiform papillae morphology J:26833
abnormal hair follicle development J:26833
abnormal hair follicle inner root sheath morphology J:26833
abnormal hair follicle orientation J:26833
abnormal hair shaft morphology J:26833
abnormal hepatocyte morphology J:26833
abnormal liver morphology J:26833
abnormal lung development J:26833
abnormal olfactory bulb morphology J:26833
abnormal tongue morphology J:26833
absent eyelids J:26833
cachexia J:26833
curly vibrissae J:26833
decreased brain size J:26833
decreased Purkinje cell number J:26833
delayed hair appearance J:26833
dilated kidney collecting duct J:26833
distorted hair follicle pattern J:26833
eyelids open at birth J:26833
increased blood urea nitrogen level J:26833
increased circulating creatinine level J:26833
perinatal lethality, complete penetrance J:26833
postnatal growth retardation J:26833
small cerebellum J:26833
thin cerebral cortex J:26833
wavy vibrissae J:26833
Egfrtm1Mag/Egfrtm1Mag
involves: 129S2/SvPas * CF-1 		abnormal inner cell mass morphology J:26833
embryonic lethality between implantation and somite formation, incomplete penetrance J:26833
Egfrtm1Mag/Egfrwa2
involves: 129S2/SvPas * B6EiC3Sn a/A-Egfrwa2 Wnt3avt * CD-1 		thick aortic valve J:60750
Egfrtm1Msi/Egfrtm1Msi
Tg(Alb1-cre)7Gsc/?
involves: 129P2/OlaHsd * C57BL/6 * FVB/N 		delayed liver regeneration J:125912
increased circulating tumor necrosis factor level J:125912
increased susceptibility to induced morbidity/mortality J:125912
slow postnatal weight gain J:125912
Egfrtm1Msi/Egfrtm1Msi
Tg(Mx1-cre)1Cgn/?
involves: 129P2/OlaHsd * C57BL/6 * CBA 		delayed liver regeneration J:125912
increased circulating tumor necrosis factor level J:125912
increased susceptibility to induced morbidity/mortality J:125912
Egfrtm1Rdk/Egfrtm1Rdk
involves: 129X1/SvJ * Black Swiss 		abnormal branching involved in lung morphogenesis J:41158
abnormal bronchus morphology J:27464, J:41158
abnormal epidermis stratum basale morphology J:27464
abnormal epidermis stratum granulosum morphology J:27464
abnormal exocrine pancreas morphology J:62160
abnormal hair follicle development J:27464
abnormal hair growth J:27464
abnormal intestinal absorption J:27464
abnormal intestine morphology J:27464
abnormal lung interstitium morphology J:41158
abnormal outer ear morphology J:27464
abnormal pancreas morphology J:62160
abnormal pancreatic beta cell morphology J:62160
abnormal pulmonary acinus morphology J:41158
abnormal pulmonary alveolus morphology J:27464, J:41158
abnormal pulmonary interalveolar septum morphology J:41158
abnormal skin appearance J:27464
abnormal submandibular gland branching morphogenesis J:69420
abnormal terminal bronchiole morphology J:41158
abnormal tongue epithelium morphology J:27464
abnormal type II pneumocyte morphology J:41158
atelectasis J:41158
cleft palate J:27464, J:54535
curly vibrissae J:27464
cyanosis J:41158
decreased alveolar lamellar body number J:41158
decreased body size J:27464
decreased embryo size J:27464
decreased fetal size J:27464
dilated respiratory conducting tube J:41158
dilated terminal bronchiole tube J:41158
disorganized pancreatic islets J:62160
dry skin J:27464
embryonic lethality during organogenesis, incomplete penetrance J:27464
eyelids open at birth J:27464
flaky skin J:27464
fused cornea and lens J:27464
hematoma J:27464
impaired lung alveolus development J:41158
increased heart rate J:27464
petechiae J:27464
pointed snout J:54535
postnatal lethality, complete penetrance J:27464
respiratory distress J:41158
respiratory failure J:41158
short mandible J:54535
small Meckel's cartilage J:54535
small pancreas J:62160
small placenta J:27464
thick pulmonary interalveolar septum J:27464, J:41158
thin epidermis J:27464
weight loss J:27464
Egfrtm1Wag/Egfrtm1Wag
involves: 129 		decreased embryo size J:26834
decreased embryo weight J:26834
embryonic lethality during organogenesis, complete penetrance J:26834
small placenta J:26834
Egfrtm1Wag/Egfrtm1Wag
involves: 129 * C57BL/6 		abnormal bronchiole epithelium morphology J:26834
abnormal epidermal layer morphology J:26834
abnormal epidermis stratum corneum morphology J:26834
abnormal hair follicle morphology J:26834
abnormal maternal decidual layer morphology J:26834
abnormal placenta morphology J:26834
abnormal pulmonary alveolus epithelium morphology J:26834
abnormal vibrissa morphology J:26834
absent vibrissae J:26834
decreased cornea thickness J:26834
decreased embryo size J:26834
decreased embryo weight J:26834
decreased spongiotrophoblast size J:26834
embryonic lethality during organogenesis, incomplete penetrance J:26834
eyelids open at birth J:26834
lethality throughout fetal growth and development, incomplete penetrance J:26834
postnatal lethality, complete penetrance J:26834
small placenta J:26834
thick pulmonary interalveolar septum J:26834
thin epidermis J:26834
Egfrtm1Wag/Egfrtm1Wag
involves: 129 * C57BL/6 * MF1 		cachexia J:26834
decreased body weight J:26834
dehydration J:26834
postnatal lethality, incomplete penetrance J:26834
EgfrVel/Egfr+
involves: C57BL/6J 		abnormal eyelid development J:88776
abnormal eyelid morphology J:88776
abnormal hair follicle orientation J:88776
cornea opacity J:88776
curly vibrissae J:88776
decreased fibroblast cell migration J:88776
eyelids open at birth J:88776
failure of eyelid fusion J:88776
microphthalmia J:88776
plush coat J:88776
waved hair J:88776
weight loss J:166602
EgfrVel/EgfrVel
involves: C57BL/6J 		abnormal trophoblast layer morphology J:88776
embryonic lethality during organogenesis, complete penetrance J:88776
placental labyrinth hypoplasia J:88776
Egfrwa2-4J/Egfrwa2-4J
involves: C57BL/6J * DBA/2J 		waved hair J:78380
Egfrwa2/Egfrwa2
B6EiC3Sn a/A-Egfrwa2 Wnt3avt/J 		abnormal hair texture J:16986
abnormal lactation J:23326
abnormal mammary gland morphology J:23326
abnormal vibrissa morphology J:16986
enlarged aortic valve J:60750
thick aortic valve J:60750
Egfrwa2/Egfrwa2
involves: C57BL/6 		abnormal aorta morphology J:241813
abnormal aortic valve morphology J:241813
abnormal heart left ventricle morphology J:241813
abnormal heart valve physiology J:241813
abnormal myocardial fiber morphology J:241813
aortic valve regurgitation J:241813
aortic valve stenosis J:241813
calcified aortic valve J:241813
cardiac fibrosis J:241813
decreased heart left ventricle muscle contractility J:241813
decreased heart right ventricle muscle contractility J:241813
decreased heart ventricle muscle contractility J:241813
heart left ventricle hypertrophy J:241813
increased cardiac stroke volume J:241813
increased heart left ventricle size J:241813
increased pulse pressure J:241813
Egfrwa2/Egfrwa2
STOCK ac 		abnormal eye morphology J:15329
abnormal hair cortex keratinization J:5260
abnormal hair medulla J:5260
cataract J:15329
curly vibrissae J:13052
decreased body size J:13052
increased curvature of guard hairs J:13052
increased curvature of hairs J:5260
short hair J:13052
short vibrissae J:13052
waved hair J:5260, J:13052
Egfrwa2/Egfrwa2
STOCK Egfrwa2 		abnormal aortic valve morphology J:60750
aortic valve regurgitation J:60750
enlarged semilunar valve J:60750
increased left ventricle systolic pressure J:60750
prolonged PR interval J:60750
prolonged RR interval J:60750
Egfrwa2/EgfrWa5
involves: BALB/cAnN * C3H/HeN * C57BL/6J 		abnormal eye morphology J:92308
abnormal fertility/fecundity J:92308
abnormal vagina orifice morphology J:92308
alopecia J:92308
asymmetric snout J:92308
decreased body weight J:92308
long snout J:92308
loss of vibrissae J:92308
mandible hypoplasia J:92308
narrow snout J:92308
perinatal lethality, incomplete penetrance J:92308
postnatal growth retardation J:92308
postnatal lethality, incomplete penetrance J:92308
EgfrWa5/Egfr+
involves: BALB/cAnN * C3H/HeN 		abnormal eye morphology J:75964
abnormal hair texture J:75964
abnormal vibrissa morphology J:75964
cornea scarring J:75964
curly vibrissae J:75964
eyelids open at birth J:75964
waved hair J:75964
EgfrWa5/Egfr+
involves: BALB/cAnN * C3H/HeN * C57BL/6J 		abnormal placenta labyrinth morphology J:92308
abnormal placenta morphology J:92308
decreased spongiotrophoblast size J:92308
EgfrWa5/EgfrWa5
involves: BALB/cAnN * C3H/HeN 		preweaning lethality, complete penetrance J:75964
EgfrWa5/EgfrWa5
involves: BALB/cAnN * C3H/HeN * C57BL/6J 		abnormal placenta labyrinth morphology J:92308
abnormal placenta morphology J:92308
decreased spongiotrophoblast size J:92308
embryonic lethality during organogenesis, incomplete penetrance J:92308
lethality throughout fetal growth and development, incomplete penetrance J:92308
Tg(Gh1-rtTA)4-3Jek/0
Tg(tetO-Egfr*)2-9Jek/0
involves: C57BL/6 * SJL 		abnormal gonadotroph morphology J:68692
abnormal reproductive system physiology J:68692
decreased body size J:68692
decreased lactotroph cell number J:68692
decreased somatotroph cell number J:68692
delayed eyelid opening J:68692
postnatal growth retardation J:68692
postnatal lethality J:68692
slow postnatal weight gain J:68692
small adenohypophysis J:68692
Tg(Prl-tTA)6-5Jek/0
Tg(tetO-Egfr*)2-9Jek/0
involves: C57BL/6 * SJL 		normal endocrine/exocrine gland phenotype J:68692
normal growth/size/body region phenotype J:68692
normal homeostasis/metabolism phenotype J:68692
normal reproductive system phenotype J:68692
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory